← FDA Drug Approvals (Drugs@FDA)

HYPROTIGEN 5%

NDA · New Drug Application · Sponsor: B BRAUN · Approved 1947-04-23

Drug application

FDA Application #

NDA006170

Application type

New Drug Application

Brand name

HYPROTIGEN 5%

Generic name

Protein Hydrolysate

Active ingredients

PROTEIN HYDROLYSATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

B BRAUN

First approval

1947-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown